Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities

von Gruber-Filbin, Mariella, Dabral, Sukriti K., Pazyra-Murphy, Maria F., Ramkissoon, Shakti, Kung, Andrew L., Pak, Ekaterina, Chung, Jarom, Theisen, Matthew A., Sun, Yanping, Franchetti, Yoko, Sun, Yu, Shulman, David S., Redjal, Navid, Tabak, Barbara, Beroukhim, Rameen, Wang, Qi, Zhao, Jean, Dorsch, Marion, Buonamici, Silvia, Ligon, Keith L., Kelleher, Joseph F., Segal, Rosalind A.
Veröffentlicht 2013

LGG-44. A PHASE I DOSE ESCALATION TRIAL OF THE MEK1/2 INHIBITOR MEK162 (BINIMETINIB) IN CHILDREN WITH LOW-GRADE GLIOMAS AND OTHER RAS/RAF PATHWAY-ACTIVATED TUMORS

von Robison, Nathan, Pauly, Jasmine, Malvar, Jemily, Gruber-Filbin, Mariella, de Mola, Rebecca Loret, Dorris, Kathleen, Bendel, Anne, Bowers, Daniel, Bornhorst, Miriam, Gauvain, Karen, Leary, Sarah, Diaz, Patricia, Tan, Yi Juin, Margol, Ashley, Dhall, Girish, Rosser, Tena, Bandopadhayay, Pratiti, Davidson, Tom, Ullrich, Nicole, Borchert, Mark, Nelson, Marvin, Sinai, Claire, Ligon, Keith, Sposto, Richard, Kieran, Mark
Veröffentlicht in Neuro Oncol (2018)